ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients' Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile Infections.

Sahil Khanna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.